Skip to main content

Motley Rice - Attorneys at Law

Menu

Navigation

Main navigation

  • Litigation Areas
  • Cases
    • Featured Cases
    • Ozempic Lawsuit
    • Hair Relaxer Lawsuit
    • Social Media Lawsuit
    • IVF Embryo Fluid Lawsuit
    • See All Cases
  • Offices
  • About
    • Frequently Asked Legal Questions
    • MDL/Complex Leadership Experience
  • Attorneys
  • Headlines
    • Press Coverage
close
Contact Us
close
search
Contact Us 1.800.768.4026
Home /
Headlines /
Glaxo ordered to pay compensation for alleged Paxil defects

Glaxo ordered to pay compensation for alleged Paxil defects

Written by: Motley Rice
Published on: October 13, 2009
Litigation Area: Medical Drugs
Category: News
Share

GlaxoSmithKline, the world's second-biggest drugmaker, was ordered in Philadelphia court today to pay compensatory damages over claims that its antidepressant, Paxil, causes birth defects. This case marks the first time a jury has considered claims that the drug manufacturer knew Paxil caused birth defects and hid the risk in order to increase profits.

Read the article featured by Bloomberg.com.

Read more about litigation involving potentially dangerous drugs.

Stay Connected

Subscribe to Motley Rice's Causes, Not Just Cases® blog to receive the latest updates delivered straight to your inbox.

Subscribe Now

 
 

You might be interested in

Blog Posts

February 17, 2023

Long overdue cosmetics safety front and center in new federal law | Causes, Not Just Cases®

by: Laura K. Stemkowski

June 11, 2021

Medical device and drug safety still a concern for women despite strides made | Causes, Not Just Cases®

by: Laura K. Stemkowski

January 28, 2021

Navigating prescription drug recalls | Causes, Not Just Cases®

by: Ann E. Rice Ervin

View All Blog Posts

News

September 18, 2025

Novo Nordisk and Eli Lilly Receive FDA Warning Letter Over Ozempic®, Wegovy®, Victoza®, Mounjaro®, Zepbound® Ads

by: Motley Rice

September 18, 2025

Does Birth Control Cause Brain Tumors?

by: Motley Rice

May 5, 2025

Studies Link Ozempic and Other GLP-1 RA Drugs to Blindness

by:
Grace P. Chandler
View All News
Motley Rice
Contact Us
1.800.768.4026

Footer menu

  • Cases
  • About Us
  • Attorneys
  • Offices
  • Litigation Areas
  • FAQs
  • Home
  • Careers
  • instagram
  • linkedin
  • facebook
  • twitter
  • bluesky
Our Commitment to You

We offer compassionate support through challenging litigation. We understand its life-altering impact. We persistently advocate for what's right, standing by your side throughout the entire process.


© Copyright 2003 - 2025 Motley Rice LLC. All rights reserved. Prior results do not guarantee a similar outcome.

Attorney Advertising.

Footer Legal

  • Privacy Policy
  • Disclaimer
Download Adobe Reader